Cargando…
Management of patients with Intestinal Bowel Disease and COVID-19: A review of current evidence and future perspectives
The COVID-19 pandemic has been a challenge for countries and health professionals worldwide. Viral entry by ACE-2 receptor and an excessive activation of the immune system are key to understand both incidence and severity of disease. Inflammatory Bowel Disease (IBD) represents a special condition as...
Autores principales: | Suria, Carles, Bosca-Watts, Marta M., Navarro, Pablo, Tosca, Joan, Anton, Rosario, Sanahuja, Ana, Revaliente, Marta, Minguez, Miguel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier España, S.L.U.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133898/ http://dx.doi.org/10.1016/j.gastre.2021.06.003 |
Ejemplares similares
-
Management of patients with Intestinal Bowel Disease and COVID-19: A review of current evidence and future perspectives
por: Suria, Carles, et al.
Publicado: (2022) -
HLA-DQ: Celiac disease vs inflammatory bowel disease
por: Bosca-Watts, Marta Maia, et al.
Publicado: (2018) -
Management of cutaneous disorders related to inflammatory bowel disease
por: Pellicer, Zaira, et al.
Publicado: (2012) -
Bowel Urgency in Ulcerative Colitis: Current Perspectives and Future Directions
por: Dubinsky, Marla, et al.
Publicado: (2023) -
Drug Development for the Irritable Bowel Syndrome: Current Challenges and Future Perspectives
por: De Ponti, Fabrizio
Publicado: (2013)